Trial Profile
A study investigating safety and efficacy of Trabectedin in patients with unresectable, advanced or metastatic soft tissue sarcomas
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Feb 2016
Price :
$35
*
At a glance
- Drugs Trabectedin (Primary)
- Indications Soft tissue sarcoma
- Focus Adverse reactions; Therapeutic Use
- 11 Feb 2016 New trial record